Induction chemotherapy in first line improves survival for locally advanced cervical cancerOctober 26, 2023
Enfortumab vedotin/pembrolizumab hailed as new standard for upfront mUCOctober 25, 2023Genitourinary Cancer
How Does Military Service Impact Cancer Risk? It’s ComplicatedOctober 25, 2023OncologyLymphoma & Plasma Cell Disorders
Study reveals potentially unnecessary CRC screening in older adultsOctober 25, 2023OncologyColon and Rectal
